Russell Investments Group
SIOX

Russell Investments Group’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Russell Investments Group’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-698
Closed -$38K – 3029
2017
Q3 		$38K Sell
698
-557
-44% -$94K ﹤0.01% 2882
2017
Q2 		$233K Buy
1,255
+348
+38% +$61K ﹤0.01% 2655
2017
Q1 		$108K Hold
907
– – ﹤0.01% 2803
2016
Q4 		$89K Buy
+907
New +$95.5K ﹤0.01% 2901

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IPLA
Ice Pond Lane Advisers New York $7.38M AUM 1.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Russell Investments Group's SIOX Position: Q4 2017 in Review

Russell Investments Group sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2017, closing a stake of 698 shares — an estimated $38K sold.

Russell Investments Group first reported a position in SIOX in Q4 2016 and held it in 4 quarters. The position peaked at $233K in Q2 2017. 104 funds tracked by Wall St. Rank hold SIOX as of Q4 2017.

  • Russell Investments Group reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Russell Investments Group sold 698 Sio Gene Therapies Inc. Common Stock shares in Q4 2017, an estimated $38K.
  • Russell Investments Group first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2016 and held it in 4 quarters.
  • Russell Investments Group's Sio Gene Therapies Inc. Common Stock position peaked at $233K in Q2 2017.
  • 104 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2017.

Based on Russell Investments Group's 13F filing for Q4 2017, filed 6 Feb 2018.